{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:48:33Z","timestamp":1792097313491,"version":"4.4.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"vor","delay-in-days":16,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006095","name":"South-Eastern Norway Regional Health Authority","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006095","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005416","name":"Research Council of Norway","doi-asserted-by":"publisher","award":["328657"],"award-info":[{"award-number":["328657"]}],"id":[{"id":"10.13039\/501100005416","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ard.2026.09.003","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:42Z","timestamp":1790121642000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ten-year outcomes after treat-to-target therapy in early rheumatoid arthritis"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6809-0573","authenticated-orcid":false,"given":"Lena Bugge","family":"Nordberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina Paulshus","family":"Sundlis\u00e6ter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gina Hetland","family":"Brinkmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Mangseth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaja E.","family":"Kj\u00f8rholt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eirik","family":"Ikdahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eirik Klami","family":"Kristianslund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eli","family":"Brodin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kari Eline Norvik","family":"Nag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilde","family":"Haukeland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ada","family":"Wier\u00f8d","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David John","family":"Stevens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian Alf","family":"H\u00f8ili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilde","family":"Stray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Lindtner","family":"Noraas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hege Kilander","family":"H\u00f8iberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnstein","family":"Bakland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel H.","family":"Solomon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe","family":"Sexton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna-Birgitte","family":"Aga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Espen A.","family":"Haavardsholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siri","family":"Lillegraven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ard.2026.09.003_bib0001","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.ard.2026.01.023","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biologic disease-modifying antirheumatic drugs: 2025 update","volume":"85","author":"Smolen","year":"2026","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.ard.2026.09.003_bib0002","doi-asserted-by":"crossref","first-page":"i4205","DOI":"10.1136\/bmj.i4205","article-title":"Ultrasound in management of rheumatoid arthritis: ARCTIC randomised controlled strategy trial","volume":"354","author":"Haavardsholm","year":"2016","journal-title":"BMJ."},{"issue":"5","key":"10.1016\/j.ard.2026.09.003_bib0003","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1136\/ard.2009.108027","article-title":"Survival, comorbidities and joint damage 11 years after the COBRA combination therapy trial in early rheumatoid arthritis","volume":"69","author":"van Tuyl","year":"2010","journal-title":"Ann Rheum Dis."},{"issue":"1","key":"10.1016\/j.ard.2026.09.003_bib0004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/03009742.2018.1466362","article-title":"Anti-cyclic citrullinated peptide antibodies, 28-joint Disease Activity Score, and magnetic resonance imaging bone oedema at baseline predict 11 years\u2019 functional and radiographic outcome in early rheumatoid arthritis","volume":"48","author":"Hetland","year":"2019","journal-title":"Scand J Rheumatol."},{"issue":"8","key":"10.1016\/j.ard.2026.09.003_bib0005","doi-asserted-by":"crossref","first-page":"523","DOI":"10.7326\/M15-0919","article-title":"Long-term outcomes of patients with recent-onset rheumatoid arthritis after 10 years of tight controlled treatment: a randomized trial","volume":"164","author":"Markusse","year":"2016","journal-title":"Ann Intern Med."},{"issue":"3","key":"10.1016\/j.ard.2026.09.003_bib0006","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1093\/rheumatology\/keae212","article-title":"Long-term clinical outcomes in early rheumatoid arthritis that was treated-to-target in the BeSt and IMPROVED studies","volume":"64","author":"Heckert","year":"2025","journal-title":"Rheumatology (Oxford)."},{"issue":"2","key":"10.1016\/j.ard.2026.09.003_bib0007","first-page":"316","article-title":"Sustained remission and reduced radiographic progression with combination disease modifying antirheumatic drugs in early rheumatoid arthritis","volume":"34","author":"M\u00e4kinen","year":"2007","journal-title":"J Rheumatol."},{"issue":"3","key":"10.1016\/j.ard.2026.09.003_bib0008","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1136\/ard.2006.057497","article-title":"Radiological damage in patients with rheumatoid arthritis on sustained remission","volume":"66","author":"Cohen","year":"2007","journal-title":"Ann Rheum Dis."},{"issue":"1","key":"10.1016\/j.ard.2026.09.003_bib0009","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/s13075-023-03176-7","article-title":"Ten-year radiographic and functional outcomes in rheumatoid arthritis patients in remission compared to patients in low disease activity","volume":"25","author":"Ruyssen-Witrand","year":"2023","journal-title":"Arthritis Res Ther."},{"issue":"1","key":"10.1016\/j.ard.2026.09.003_bib0010","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1136\/rmdopen-2023-003860","article-title":"Patient-reported outcomes and radiographic progression in patients with rheumatoid arthritis in sustained remission versus low disease activity","volume":"10","author":"Snoeck Henkemans","year":"2024","journal-title":"RMD Open."},{"issue":"7","key":"10.1016\/j.ard.2026.09.003_bib0011","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1002\/acr.23112","article-title":"Do short and sustained periods of American College of Rheumatology\/European League Against Rheumatism remission predict functional and radiographic outcome in early rheumatoid arthritis patients with low overall damage progression?","volume":"69","author":"Konijn","year":"2017","journal-title":"Arthritis Care Res."},{"issue":"9","key":"10.1016\/j.ard.2026.09.003_bib0012","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1136\/ard.2010.138461","article-title":"2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"69","author":"Aletaha","year":"2010","journal-title":"Ann Rheum Dis."},{"issue":"3","key":"10.1016\/j.ard.2026.09.003_bib0013","first-page":"579","article-title":"Development of a disease activity score based on judgment in clinical practice by rheumatologists","volume":"20","author":"van der Heijde","year":"1993","journal-title":"J Rheumatol."},{"issue":"1","key":"10.1016\/j.ard.2026.09.003_bib0014","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1136\/ard-2022-223413","article-title":"American College of Rheumatology\/EULAR remission criteria for rheumatoid arthritis: 2022 revision","volume":"82","author":"Studenic","year":"2023","journal-title":"Ann Rheum Dis."},{"issue":"11","key":"10.1016\/j.ard.2026.09.003_bib0015","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1136\/ard.2011.152926","article-title":"Examination of intra and interrater reliability with a new ultrasonographic reference atlas for scoring of synovitis in patients with rheumatoid arthritis","volume":"70","author":"Hammer","year":"2011","journal-title":"Ann Rheum Dis."},{"issue":"3","key":"10.1016\/j.ard.2026.09.003_bib0016","first-page":"743","article-title":"How to read radiographs according to the Sharp\/van der Heijde method","volume":"26","author":"van der Heijde","year":"1999","journal-title":"J Rheumatol."},{"issue":"12","key":"10.1016\/j.ard.2026.09.003_bib0017","first-page":"2221","article-title":"Validity and measurement precision of the PROMIS physical function item bank and a content validity-driven 20-item short form in rheumatoid arthritis compared with traditional measures","volume":"54","author":"Oude Voshaar","year":"2015","journal-title":"Rheumatology (Oxford)."},{"issue":"5","key":"10.1016\/j.ard.2026.09.003_bib0018","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1093\/rheumatology\/36.5.551","article-title":"Measuring health-related quality of life in rheumatoid arthritis: validity, responsiveness and reliability of EuroQol (EQ-5D)","volume":"36","author":"Hurst","year":"1997","journal-title":"BrJRheumatol."},{"issue":"6","key":"10.1016\/j.ard.2026.09.003_bib0019","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1136\/ard.2010.142901","article-title":"Finalisation and validation of the rheumatoid arthritis impact of disease score, a patient-derived composite measure of impact of rheumatoid arthritis: a EULAR initiative","volume":"70","author":"Gossec","year":"2011","journal-title":"Ann Rheum Dis."},{"issue":"6","key":"10.1016\/j.ard.2026.09.003_bib0020","first-page":"473","article-title":"The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"MedCare"},{"key":"10.1016\/j.ard.2026.09.003_bib0021","unstructured":"Steene-Johannessen J, Hansen BH, Teinung E, Kolle E, Riiser A, M\u00f8lmen KS, et al. Physical fitness among adults and older adults in Norway 2022-23 (Kan3) [Internet]. Citation date 15.06.2026, Available from: https:\/\/www.fhi.no\/contentassets\/5b5795f716614735a29ad4cb636fe1fd\/rapport-kan3_fase2_25.08.24.pdf"},{"issue":"14","key":"10.1016\/j.ard.2026.09.003_bib0022","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1016\/j.ejca.2011.03.011","article-title":"Choosing the relative survival method for cancer survival estimation","volume":"47","author":"Hakulinen","year":"2011","journal-title":"Eur J Cancer."},{"issue":"11","key":"10.1016\/j.ard.2026.09.003_bib0023","doi-asserted-by":"crossref","first-page":"5073","DOI":"10.1093\/rheumatology\/keab398","article-title":"Current favourable 10-year outcome of patients with early rheumatoid arthritis: data from the ESPOIR cohort","volume":"60","author":"Combe","year":"2021","journal-title":"Rheumatology (Oxford)."},{"issue":"2","key":"10.1016\/j.ard.2026.09.003_bib0024","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1136\/ard-2023-224814","article-title":"Long-term mortality in treated-to-target RA and UA: results of the BeSt and IMPROVED cohort","volume":"83","author":"Heckert","year":"2024","journal-title":"Ann Rheum Dis."},{"issue":"6","key":"10.1016\/j.ard.2026.09.003_bib0025","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.ard.2026.01.003","article-title":"Successful discontinuation of oral glucocorticoids after short-term bridging therapy in patients with newly diagnosed rheumatoid arthritis","volume":"85","author":"Brinkmann","year":"2026","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.ard.2026.09.003_bib0026","first-page":"10","article-title":"Tapering of conventional synthetic disease modifying anti-rheumatic drugs in rheumatoid arthritis patients in sustained remission: results from a randomized controlled trial","volume":"71","author":"Lillegraven","year":"2019","journal-title":"Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.ard.2026.09.003_bib0027","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1136\/annrheumdis-2020-eular.1955","article-title":"Stable versus tapered and withdrawn treatment with tumor necrosis factor inhibitor in rheumatoid arthritis remission (ARCTIC REWIND): a randomised, open-label, phase 4, non-inferiority triial","volume":"79","author":"Lillegraven","year":"2020","journal-title":"Ann Rheum Dis."},{"issue":"17","key":"10.1016\/j.ard.2026.09.003_bib0028","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1001\/jama.2021.4542","article-title":"Effect of half-dose vs stable-dose conventional synthetic disease-modifying antirheumatic drugs on disease flares in patients with rheumatoid arthritis in remission: the ARCTIC REWIND randomized clinical trial","volume":"325","author":"Lillegraven","year":"2021","journal-title":"JAMA"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496726005534?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496726005534?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:34:53Z","timestamp":1792096493000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496726005534"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":28,"alternative-id":["S0003496726005534"],"URL":"https:\/\/doi.org\/10.1016\/j.ard.2026.09.003","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ten-year outcomes after treat-to-target therapy in early rheumatoid arthritis","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ard.2026.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V. on behalf of European Alliance of Associations for Rheumatology (EULAR).","name":"copyright","label":"Copyright"}]}}